Evaluate Ltd

Last year's unpredictable times have – for the most part – settled down, bringing steadier trends into play. Download the World Preview 2024 #Infographic to see which drugs, therapy areas, breakthroughs and broader developments are set to shape the pharma market’s future. 👉 https://ow.ly/jn5R50SvNQV

In the competitive landscape of drug development and commercialisation, making strategic decisions that bring value to your stakeholders and patients is crucial. Evaluate Ltd's tailored commercial solutions help to provide: 📊 Objective risk and return analysis to ensure the long-term health of your pipeline. 🔍 Streamline your search and screening process for in-licensing and out-licensing opportunities, leading to successful deals.  🤝 Partnerships that drive innovation and help you achieve your strategic goals more efficiently. Find our how our experts can help you and your strategy today: https://lnkd.in/eW8xEA55 #Pharmaceuticals #Innovation #Strategy

Our upcoming World Preview #report forecasts the prescription drug market will hit over $1.7 trillion in worldwide sales in 2030 – that’s a growth rate of 7.7%. What’s driving it? It’s not ALL obesity, there are several therapy areas in the spotlight and we’ll digging into the detail in the report when it’s released next week! Stay tuned! 📢 Pre-register for the report and you'll receive it as soon as it launches: https://lnkd.in/emS2DMJk #Biopharma #Biotech

Beyond the patent cliff: Are your models forecasting the full market picture? Will your #pharmaceutical #forecasts withstand the impact of a patent expiry, whether it's your product or a competitor's? J+D Forecasting's new #report explores how to incorporate these market shifts into your forecasting models. Learn more: https://ow.ly/7LNC50SrMrk

Our World Preview #webinar is just a couple of weeks away and our expert panel have been planning! For a sneak peek of what you can expect of the session, check out this new #blog by panellist Paul Verdin who shares a few of #pharma themes under discussion. Click here to read now: https://lnkd.in/gCJxbXZF

In the competitive and complex #CDMO landscape, do you have the insights you need to make confident recommendations? Evaluate Ltd provides tailored data and tools that empower you to profile and compare CDMOs, select the right vendor, and reinforce your position as a leading advisor in the space. Evaluate can help you to: 📊 Gain an objective view of the CDMO landscape and market size. 🏆 Identify the leading CDMOs in each technology area. 💡 Analyse CDMO facilities and service offerings to assess strengths and weaknesses. 💊 Understand which CDMO a pharma company currently uses for drug manufacturing. Learn more about the CDMO Intelligence you need now: https://lnkd.in/gVpJGjkg

Our World Preview #webinar in July will provide highlights from our upcoming state of the nation #report. What are you most interested to hear about? Comment below 👇 📅 Register for the webinar here: https://lnkd.in/egMuqyjv

The biggest challenge for #BusinessDevelopment & #Licensing teams right now is the increasing availability of information, with rapidly changing business strategies and limited resources. Are they're finding innovative ways to overcome these obstacles and focus on company goals? In this new #video, Ben Folwell discusses the biggest challenges and trends facing BD&L teams.

📢 Evaluate’s first forecasts to 2030 are in! 📢 Sign up for our upcoming #webinar and see further down the road ahead.    During the webinar, we'll look at how patent expiries will impact the top 20 pharma companies, which pipeline assets will lead the NPV rankings, and how hot new modalities like ADCs, radiopharmaceuticals radiopharma, RNA therapies and gene-modified cell therapies will shape the future.  Secure your spot here: https://lnkd.in/egMuqyjv

How have leading #pharmaceutical companies managed their finances over the past decade to drive innovation and ROI? Our latest analysis reveals the spending patterns of the top 15 companies in 2023. Discover how they balance investment in R&D with strategic #acquisitions and #licensing deals to achieve the best results. 💰 Get the full story here: https://ow.ly/U8TV50SlJJh